The Big Heat

Posted: 07/10/14

Barbara Ryan is a Managing Director in the Healthcare Capital Markets and Strategic Communications practices at FTI Consulting. Ryan, who also has years of experience as a Wall Street sell-side research analyst covering the biopharmaceutical industry, recently moderated a panel discussion with several other life sciences and investment experts on the boom in life science mergers and acquisitions, as well as the issues and challenges confronting pharmaceutical companies both large and small as they attempt to compete in a complex global market. That discussion, in edited version, ran in the June issue of FTI Journal here.

Ryan turned the meat of that wide-ranging conversation into an incisive article, “The Big Heat: What Lies Behind the Mergers, Acquisitions, and Consolidations in the Life Sciences,” which the Bloom Group helped her publish in July in Outsourced Pharma, here.